Clinical Trial Update: Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating intensity-modulated radiation therapy to treat nasopharyngeal cancer while sparing the contralateral parotid gland function;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Snippet

Sponsor: Alberta Health services | Conditions: Nasopharyngeal Neoplasms | Phase 1, Phase 2 | Status: COMPLETED